Xeris Pharmaceuticals | XERS - بدهی های جاری

قیمت سهام
5.46
تغییر روزانه
-0.02 -0.37%
ماهیانه
-20.98%
سالیانه
13.28%
Q1 پیش بینی
5.30




بدهی های جاری تغییر دادن تاریخ
Celltrion KRW 4.01T 343.96B 2025-09
Cspc Pharmaceutical CNY 10.11B 478.47M 2025-06
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Divis Laboratories Ltd INR 17.28B 2.76B 2025-09
Eli Lilly USD 35.23B 4.91B 2025-12
Kangmei Pharma CNY 5.81B 57.93M 2025-09
Knight Therapeutics CAD 118.15M 12.32M 2024-09
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organigram Holdings CAD 126.16M 18.88M 2025-09
Ovoca Bio EUR 2.44M 1.1M 2022-06
Pacira USD 120.59M 13.51M 2025-12
Perrigo USD 1.01B 132.4M 2025-12
Pharma Mar EUR 93.88M 4.94M 2025-12
Qiagen NV USD 512.14M 461.26M 2025-12
Sartorius EUR 1.81B 254.3M 2025-09
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
Tilray USD 280.3M 18.13M 2025-03
Zz Pientze Pharmaceu CNY 2.14B 1.06B 2025-09